Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE14180.0545.9 (+0.32 %)

PREV CLOSE ( ) 14134.15

OPEN PRICE ( ) 14211.85

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1146

TODAY'S LOW / HIGH ( )13788.00 14263.55

52 WK LOW / HIGH ( )5532.5 18089.55

NSE14193.8570.5 (+0.5 %)

PREV CLOSE( ) 14123.35

OPEN PRICE ( ) 14125.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8127

TODAY'S LOW / HIGH( ) 13800.00 14282.70

52 WK LOW / HIGH ( )5540.1 18100

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984

Management Info

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

22Jan Neuland Laboratories leads the gainers
Neuland Laboratories is currently trading at Rs. 13838.00, up by 641.95..

03Jan Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..

24Dec Neuland Laboratories informs about upd
Pursuant to Company’s Insider Trading Code read with SEBI PIT Regulation..

13Dec Neuland Laboratories informs about dis
In reference to the letter dated November 23, 2022, regarding approval o..

29Nov Neuland Laboratories informs about dis
Neuland Laboratories has informed that the exchange has received the dis..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	319.59	2995.96
Gross Profit	485.39	4007.69
Operating Profit	656.75	4744.65
Net Sales	3108.44	15585.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 7441.40 (2.96%)	M.Cap ( in Cr)18603.50
Wockhardt (BSE) 1557.15 (10.00%)	M.Cap ( in Cr)25299.38
Medplus Health Servi (BSE) 787.20 (8.64%)	M.Cap ( in Cr)9422.30
Suven Pharma (BSE) 1108.25 (4.99%)	M.Cap ( in Cr)28212.16
Bajaj Healthcare (BSE) 690.80 (8.20%)	M.Cap ( in Cr)2181.77

Shareholding Pattern

	NON-INSTITUTION	33.97%
	PROMOTERS	32.68%
	MUTUAL FUNDS/UTI	6.29%
	FI/BANKS/INSURANCE	0.57%
	GOVERNMENT	0.4%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
LIC MF Healthcare F...	3.39
HSBC Small Cap Fund...	2.36
HSBC Multi Cap Fund...	1.72
Motilal Oswal Nifty...	1.55
WOC Pharma and Heal...	1.46
Mahindra Manulife L...	1.45
Bandhan Innovation ...	1.18

Risk Disclosures on Derivatives

Smart Quotes

NEULAND LABORATORIES LTD.